New daily pill could help shed pounds without diabetes
NCT ID NCT07166081
First seen Oct 01, 2025 · Last updated May 05, 2026 · Updated 27 times
Summary
This early-stage study tests an experimental daily pill, BGM0504, in 80 non-diabetic adults who are overweight or obese. The main goal is to check safety and how the body processes the drug, while also measuring weight changes over 11 weeks. Participants are randomly assigned to receive either the drug or a placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-DIABETIC OVERWEIGHT OR OBESE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Pharmaron CPC, Inc
RECRUITINGBaltimore, Maryland, 21201, United States
Conditions
Explore the condition pages connected to this study.